Mark V. Anquillare - Nov 22, 2021 Form 4 Insider Report for Verisk Analytics, Inc. (VRSK)

Role
Group President and COO
Signature
/s/ Kathy Card Beckles, Attorney-in-Fact
Stock symbol
VRSK
Transactions as of
Nov 22, 2021
Transactions value $
-$3,465,760
Form type
4
Date filed
11/22/2021, 04:19 PM
Next filing
Dec 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRSK Common Stock Options Exercise $1.25M +20.5K +95.24% $61.14 42K Nov 22, 2021 Direct
transaction VRSK Common Stock Sale -$665K -2.9K -6.91% $229.30 39.1K Nov 22, 2021 Direct F1
transaction VRSK Common Stock Sale -$2.87M -12.4K -31.82% $230.40 26.6K Nov 22, 2021 Direct F2
transaction VRSK Common Stock Sale -$1.19M -5.14K -19.3% $230.92 21.5K Nov 22, 2021 Direct F3
holding VRSK Common Stock 57K Nov 22, 2021 By Trust F4
holding VRSK Common Stock 9.03K Nov 22, 2021 By Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRSK Stock Option Options Exercise $0 -20.5K -50% $0.00 20.5K Nov 22, 2021 Common Stock 20.5K $61.14 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $228.73 to $229.69, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1).
F2 These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $229.74 to $230.71, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2).
F3 These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $230.75 to $231.26, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3).
F4 These shares of common stock are held by the Mark Anquillare Spousal Living Trust.
F5 These shares of common stock are held in a Revocable Trust.
F6 This stock option was granted under the Issuer's 2009 Equity Incentive Plan.
F7 Immediately.